iBerotech raised 15 million euros in Seed funding to advance MaiRa, its first-trimester platform for predicting pregnancy complications from a single maternal blood draw.
Public source
Publisher name
Public post
🇪🇸 iPremom, the molecular diagnostics company based at the Parc Científic de la Universitat de Valencia cluster in Paterna, has raised 15 million euros in Seed funding…
Company
iBerotech
B2B Sales & Growth | Outreach Services | Strategic Partnerships in Iberia
- Industry
- Business Consulting and Services
- Location
- Madrid, ES
- Company size
- 2–10 employees
About iBerotech
At iBerotech, we operate as a B2B outreach agency delivering qualified sales opportunities for selected tier-1 organisations in Spain, Portugal, and Italy. Our performance-based model guarantees cash-positive RevOps for our partners. With an extensive network of influential public officials and market operators, we facilitate valuable connections and accelerate market entry. Our expertise spans fintech, e-commerce, and digital transformation, providing clients with actionable insights and cost-effective sales solutions.
See moreLatest activity
Latest activity from iBerotech
9 signals
Capital & Finance
iBerotech announced that Hope Care, a Portuguese digital health company founded in 2012, closed a 6 million euros Series A funding round to carry its regulated remote patient monitoring platform into four European markets including France, Germany, Switzerland, and Romania.
Customers & Market
iBerotech reports that Spain's exports to Morocco reached 12.330 billion euros in 2025, making Morocco the third destination for Spanish goods outside the EU.
Legal & Regulatory
iBerotech is not a business signal about the author's company, but the Portuguese government asked both Air France-KLM and Lufthansa to sharpen their binding bids for a 44,9% stake in TAP Air Portugal on 4 September 2026.
Discover more
Similar signals
Similar public activity from other companies.
Capital & Finance
Asabys Partners
Asabys Partners co-led a €15m seed round in iPremom, a technological platform combining molecular diagnostics and AI, predicting pregnancy complications from the first trimester through a simple blood test.
Capital & Finance
Scaling Europe
Scaling Europe's iPremom company raised €15m Seed funding.
Capital & Finance
Alantra
Alantra's strategic partner, Asabys Partners, co-led a €15 million seed financing round in iPremom, a molecular diagnostics company specializing in women's health.
Capital & Finance
Amadeus Capital Partners
Amadeus Capital Partners raised €15m to identify the risk months earlier for pregnancy complications, led by Amadeus, alongside APEX Ventures and Asabys Partners.
Capital & Finance
Future4care